Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 1
2009 1
2014 3
2015 1
2017 2
2018 4
2019 1
2020 1
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Thrombophilic disorders in migraine.
Cavestro C, Mandrino S. Cavestro C, et al. Front Neurol. 2014 Jul 10;5:120. doi: 10.3389/fneur.2014.00120. eCollection 2014. Front Neurol. 2014. PMID: 25071708 Free PMC article. Review. No abstract available.
Coexistence of antiphospholipid antibodies and cephalalgia.
Islam MA, Alam F, Gan SH, Cavestro C, Wong KK. Islam MA, et al. Among authors: cavestro c. Cephalalgia. 2018 Mar;38(3):568-580. doi: 10.1177/0333102417694881. Epub 2017 Feb 20. Cephalalgia. 2018. PMID: 28952322 Review.
Migraine in Systemic Autoimmune Diseases.
Cavestro C, Ferrero M. Cavestro C, et al. Endocr Metab Immune Disord Drug Targets. 2018 Feb 13;18(2):124-134. doi: 10.2174/1871530317666171124124340. Endocr Metab Immune Disord Drug Targets. 2018. PMID: 29173190 Review.
Novelty in Inflammation and Immunomodulation in Migraine.
Cavestro C, Ferrero M, Mandrino S, Di Tavi M, Rota E. Cavestro C, et al. Curr Pharm Des. 2019;25(27):2919-2936. doi: 10.2174/1381612825666190709204107. Curr Pharm Des. 2019. PMID: 31686633 Review.
Melatonin and Sleep Disturbances in Alzheimer's Disease.
Prodhan AHMSU, Cavestro C, Kamal MA, Islam MA. Prodhan AHMSU, et al. Among authors: cavestro c. CNS Neurol Disord Drug Targets. 2021;20(8):736-754. doi: 10.2174/1871527320666210804155617. CNS Neurol Disord Drug Targets. 2021. PMID: 34348635 Review.
ATXN2 polyQ intermediate repeats are a modifier of ALS survival.
Chiò A, Calvo A, Moglia C, Canosa A, Brunetti M, Barberis M, Restagno G, Conte A, Bisogni G, Marangi G, Moncada A, Lattante S, Zollino M, Sabatelli M, Bagarotti A, Corrado L, Mora G, Bersano E, Mazzini L, D'Alfonso S; PARALS. Chiò A, et al. Neurology. 2015 Jan 20;84(3):251-8. doi: 10.1212/WNL.0000000000001159. Epub 2014 Dec 19. Neurology. 2015. PMID: 25527265 Free article.
16 results